Medplus Health (MEDPLUS) | Stock Overview & Key Data
Medplus Health Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹1,343.00 on January 17, 2022
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Medplus Health
MEDPLUS
|
108.75B Mid-cap | 2.21% | -8.44% | 5.44% | 7.75% | 7.41% | 0.15% | 10.40% | -18.04% | -18.04% | -18.04% | -18.04% |
|
One Global Service
ONEGLOBAL
|
11.05B Small-cap | 16.81% | 49.06% | 10.17% | 9.68% | 2.93% | 143.76% | 1,875.38% | 6,435.05% | 9,804.69% | 6,239.00% | 6,239.00% |
|
Sastasundar Ventures
SASTASUNDR
|
8.58B Small-cap | -7.90% | -0.76% | -0.39% | -6.65% | -4.75% | 0.57% | -2.95% | -7.26% | 307.99% | 612.04% | 173.38% |
|
Trident Lifeline
TLL
|
3.01B Small-cap | 4.71% | 0.37% | 5.56% | -15.18% | -20.24% | -7.91% | 74.46% | 146.14% | 146.14% | 146.14% | 146.14% |
|
Achyut Healthcare
ACHYUT
|
1.31B Small-cap | -0.15% | 33.47% | 15.44% | 17.50% | 23.68% | 86.78% | -82.04% | -66.67% | -66.67% | -66.67% | -66.67% |
|
Dipna Pharmachem
DPL
|
228.19M Small-cap | -10.08% | -4.80% | -24.84% | -48.60% | -58.61% | -68.24% | -97.06% | -96.96% | -92.04% | -93.84% | -93.84% |
Ownership & Short Interest
Calculate Your Medplus Health Investment Returns
Long-Term Investment Performance Analysis
Medplus Health stock price in Dec 2021 was ₹1,076.05, A ₹1,000.00 lump sum investment in Medplus Health made 4 years ago would be worth approximately ₹809.16 today, representing a negative return of -19.08%. This translates to an annualized return (CAGR) of -4.61%.
4 Years 5 Months Investment Scenario (Dec 2021 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is MEDPLUS's 52-week high and low?
- In the last 52 weeks, Medplus Health reached a high of ₹1,022.20 (on May 21, 2026) and a low of ₹732.00 (on October 3, 2025).
- What is the market cap and P/E ratio for MEDPLUS?
- Curious about Medplus Health's size and valuation? Its market capitalization stands at 108.75B. When it comes to valuation, the P/E ratio (trailing twelve months) is 52.45, and the forward P/E (looking ahead) is 44.24.
- Does MEDPLUS pay dividends? If so, what's the yield?
- As for dividends, Medplus Health isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Medplus Health's main competitors or similar companies to consider before investing?
When looking at Medplus Health, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return One Global Service
ONEGLOBAL11.05B Healthcare Pharmaceutical Retailers 143.76% 1,875.38% Sastasundar Ventures
SASTASUNDR8.58B Healthcare Pharmaceutical Retailers 0.57% -2.95% Trident Lifeline
TLL3.01B Healthcare Pharmaceutical Retailers -7.91% 74.46% Achyut Healthcare
ACHYUT1.31B Healthcare Pharmaceutical Retailers 86.78% -82.04% Dipna Pharmachem
DPL228.19M Healthcare Pharmaceutical Retailers -68.24% -97.06% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Medplus Health Services Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Medplus Health's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 8.64%, the Debt to Equity ratio from the most recent quarter is 64.69, and its Gross Profit Margin stands at 26.16%.
- What is the recent revenue and earnings growth for MEDPLUS?
- Looking at Medplus Health's growth, its revenue over the trailing twelve months (TTM) was INR65B. Compared to the same quarter last year (YoY), quarterly revenue grew by 15.70%, and quarterly earnings saw a YoY growth of 26.00%.
- How much of MEDPLUS stock is held by insiders and institutions?
- Wondering who owns Medplus Health stock? Company insiders (like executives and directors) hold about 41.74% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 35.32%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.